Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00579774 · ClinicalTrials.gov registry record · NA

Effects of Glycoxidative Stress on Human Aging

A NA study, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
NA
Development phase
438
Enrollment target

NCT00579774: Completed NA study, sponsored by Icahn School of Medicine at Mount Sinai.

NCT00579774 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 438 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00579774, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
NA
Development phase
438 participants
Enrollment target

Study Summary

Advanced glycation products or AGEs are a heterogeneous group of molecules formed by exposure of tissue constituents to high levels of reducing sugars, e.g. glucose. The interaction of these compounds with extra- and intra-cellular components may account in part for several conditions related to aging. It has recently been recognized that AGEs are also formed during the preparation of food by heating, are absorbed into the circulation and become largely incorporated into tissue components. Accumulation of these exogenous substances over time may, together with those generated endogenously, contribute to the clinical manifestations and complications of aging. This is an interventional-randomized study in which we are trying to determine whether a diet low in AGE can effectively reduce circulating AGE levels, with or without altering oxidation or inflammatory markers, in a subset of both young and older subjects , over a period of 4 months. If positive results are obtained, longer-term prospective studies will be designed to determine if this intervention can affect disease outcomes in older age subjects. The study design is very simple and consists initially of obtaining a dietary history, a blood sample, 24-hour urine collection and, subsequently, of determining the effects of a low-AGE diet for 4 months on the plasma levels of these compounds in a group of healthy subjects.

Interventions

  • OTHER Regular Diet
  • OTHER Low AGE Diet

Trial Details

FieldValue
Enrollment Target 438 participants
Start Date 2007-01
Est. Completion 2011-10
Phase NA

What the finished NCT00579774 record still lists

NCT00579774 is an interventional study that assigns participants to a tested intervention. The registered 438 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).

The record links to 0 conditions, and to 2 interventions - of which Regular Diet is the first listed.

NCT00579774 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00579774 about?

NCT00579774 is a clinical study titled "Effects of Glycoxidative Stress on Human Aging". Advanced glycation products or AGEs are a heterogeneous group of molecules formed by exposure of tissue constituents to high levels of reducing sugars, e.g. glucose. The interaction of these compounds with extra- and intra-cellular components may account in part for several conditions related to agi...

What is the current status of trial NCT00579774?

This trial is currently completed. It is a NA study. The enrollment target is 438 participants. The study started on 2007-01. Estimated completion is 2011-10.

What interventions are being tested in trial NCT00579774?

The interventions under investigation include: Regular Diet (OTHER), Low AGE Diet (OTHER).

Who is sponsoring clinical trial NCT00579774?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00579774's enrollment target sits among peer trials

438 235th of 2000 higher than 1,766 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05711446 · 438 participants · NA

    Double Voiding and Post-transplant UTI

  • NCT05421663 · 439 participants · Phase 1

    A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma

  • NCT06235151 · 439 participants · Phase 3

    Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer

  • NCT05114538 · 440 participants · NA

    Improving the Part C Early Intervention Service Delivery System for Children with ASD

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00579774, the US trial registry maintained by the National Library of Medicine. NCT00579774 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.